Nushin Rashidian
Co-Founder and Editor at Cannabis Wire
Founding editor @cannabiswire; teach @columbiajourn; author @thenewpress
Articles
-
2 weeks ago |
cannabiswire.com | Nushin Rashidian
Hemp briefly took the spotlightduring a House committee hearing on Wednesday that was focused on cutting what Republicans say is excessive red tape at the U.S. Food and Drug Administration. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates.
-
1 month ago |
cannabiswire.com | Nushin Rashidian
At the New York Cannabis Control Board meeting on Thursday, regulators proposed a slow down of cultivation licensing and loosening restrictions on retailers who want to offer cannabis discounts. They also lifted the hood for the first time on some trade investigations underway. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise.
-
1 month ago |
cannabiswire.com | Nushin Rashidian
Dozens of countries voted on Wednesday to place an intoxicating cannabis plant-derived compound called HHC under the control of an international drug treaty. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates. Subscribe now. Already a subscriber? Sign in
-
1 month ago |
cannabiswire.com | Nushin Rashidian
California’s cannabis industry continues to face a cascade of challenges, but it still holds signs of growth. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates. Subscribe now. Already a subscriber? Sign in
-
Jan 14, 2025 |
cannabiswire.com | Nushin Rashidian
A months-long hearing on cannabis rescheduling that was set to begin on Jan. 21 has been put on hold following a push by rescheduling advocates to have the Drug Enforcement Administration removed from the process due to alleged bias. Don’t miss out. Subscribe now for instant access. Save time with reporting on cannabis policy, regulation, and research – from journalists with more than a decade of subject-matter expertise. Email [email protected] for team and non-profit rates.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 1K
- Tweets
- 4K
- DMs Open
- No
RT @CannabisWire: New York just legalized cannabis. Who lobbied on the issue this year? A wide range of entities, including those that rep…
RT @CannabisWire: China's hemp industry sees new possibilities as hemp-derived CBD products hit the market and provinces draw up rules. A…
RT @HayesBrown: This piece really owes a lot to the work that @alysonrmartin and @msamandalewis have been doing covering the cannabis legal…